This opinion article by The University of Texas System Chancellor James B. Milliken mentions UT Health San Antonio and the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases. Read More (subscription required)
Share This Story
Sudha Seshadri, MD, founding director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was quoted in this article. Read More (subscription required)
Share This Story
Sudha Seshadri, MD, director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, and Kevin Bieniek, PhD, co-director of the Biggs Institute Brain Bank, were interviewed for this news story. Watch Now
Share This Story
Research by Sandeep Burma, PhD, professor and vice chair (research), and Bipasha Mukherjee, PhD, associate professor, both with the Department of Neurosurgery, was featured in this article. Read More
Share This Story
Sandeep Burma, PhD, professor and vice chair (research), Department of Neurosurgery, was quoted in this article and Bipasha Mukherjee, PhD, associate professor, Department of Neurosurgery, was mentioned in this article. Read More
Share This Story
Research by Sandeep Burma, PhD, professor and vice chair (research), and Bipasha Mukherjee, PhD, associate professor, both with the Department of Neurosurgery, was featured in this article. Read More
Share This Story
Sandeep Burma, PhD, professor and vice chair (research), Department of Neurosurgery, was quoted in this article and Bipasha Mukherjee, PhD, associate professor, Department of Neurosurgery, was mentioned in this article. Read More
Share This Story
Researchers at The University of Texas Health Science Center at San Antonio have discovered a way to delay or even block recurrence of the deadliest brain cancer after radiation, bringing new hope for survival.
Share This Story
New hope for adult sufferers of most common primary brain tumor A drug developed at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been shown to extend survival for patients with glioblastoma, the most common primary brain tumor in adults. Results of a trial led by the university revealed that […]
Share This Story
Hispanics face nearly double the risk of developing Alzheimer’s disease compared to non-Hispanic whites, according to the National Institutes of Health National Institute on Aging.
Share This Story